Treatment News : WHO TasP Guidelines Will Benefit Few in the Ivory Coast

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Treatment News » July 2014

Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More Treatment News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


July 9, 2014

WHO TasP Guidelines Will Benefit Few in the Ivory Coast

The World Health Organization’s (WHO) 2013 guidelines for using antiretrovirals (ARVs) to prevent the transmission of HIV will benefit a mere fraction of the targeted group in the Ivory Coast, aidsmap reports. WHO advises that all people with HIV, regardless of CD4 levels, should take ARVs if they have an HIV-negative partner. Research has shown that ARVs lower the likelihood of transmitting HIV in mixed-HIV status couples to potentially negligible levels—a paradigm known as treatment as prevention, or TasP.

Publishing their findings in the journal AIDS, researchers conducted interviews in the west African nation of 929 HIV-positive people whose CD4s were above 500, aksking them about their partnership status and the HIV status of their partners. Seventy-two percent of the participants, who were interviewed in 2012, had a stable sexual partner. Of this group, 67 percent had revealed their HIV status to their partner, and 59 percent knew their partner’s HIV status. Eighty-two percent of those who had disclosed their own HIV status to their partner knew the partner’s HIV status, compared with just 10 percent of those who had not self-disclosed.

Thirty percent were not in a stable sexual relationship, 24 percent were in a partnership with an HIV-positive person, and 34 percent were in a stable partnership but did not know the HIV status of their partner. This left just 12 percent who were in a stable sexual relationship with someone they knew was HIV negative—the only segment of the group that would ultimately be subject to these particular WHO recommendations about starting ARVs.

To read the aidsmap story, click here.

To read the study abstract, click here.

Search: TasP, treatment as prevention, HIV, World Health Organization, WHO, Ivory Coast, AIDS, guidelines, aidsmap.

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (0 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.